STAAR Surgical's merger with Alcon terminated after shareholder vote; no fee

STAAR SURGICAL CO

Merger agreement with Alcon terminated effective Jan 6, 2026; no termination fee payable.
Special meeting held same day; 87.9% of shares represented (43,367,928 of 49,365,823).
Merger proposal not approved: 14,904,915 For, 27,339,877 Against, 1,123,136 abstain.
Compensation proposal not approved: 14,224,065 For, 27,905,792 Against, 1,238,071 abstain.
Both parties bear their own costs and expenses under the Merger Agreement.

item 1.02 item 5.07

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

STAAR SURGICAL CO terminated Agreement and Plan of Merger with Alcon Research, LLC (effective 2026-01-06).

Action: termination
Agreement: merger
Counterparty: Alcon Research, LLC
Effective: 2026-01-06

Exact text from the filing

As previously disclosed, on August 4, 2025, STAAR Surgical Company (the “Company”) entered into an Agreement and Plan of Merger, dated as of August 4, 2025 (as amended, the “Merger Agreement”), by and among the Company, Alcon Research, LLC (“Alcon”) and Rascasse Merger Sub, Inc.

View on SEC.gov

281 material agreements filed in the last 30 days. Browse all material agreements →

STAAR SURGICAL CO filing history →

Source: SEC EDGAR

accession 0001193125-26-004699

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.